news
A team has found that their drug Molnupiravir (MK-4482/EIDD-2801) acts…
4 December 2020 | By Victoria Rees (Drug Target Review)
A team has found that their drug Molnupiravir (MK-4482/EIDD-2801) acts as an antiviral against SARS-CoV-2 in pre-clinical studies.